Grey Wolf Health Corp.
WOLF.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.45M | 6.29M | 6.44M | 6.78M | 6.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.45M | 6.29M | 6.44M | 6.78M | 6.88M |
| Cost of Revenue | 3.31M | 2.89M | 3.10M | 3.21M | 3.04M |
| Gross Profit | 4.13M | 3.40M | 3.34M | 3.57M | 3.84M |
| SG&A Expenses | 2.92M | 2.56M | 2.39M | 2.29M | 2.41M |
| Depreciation & Amortization | 321.60K | 325.00K | 330.20K | 345.20K | 329.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.55M | 5.78M | 5.82M | 5.85M | 5.79M |
| Operating Income | 893.30K | 516.20K | 626.70K | 930.60K | 1.10M |
| Income Before Tax | 567.40K | 193.40K | 293.60K | 602.10K | 764.80K |
| Income Tax Expenses | 213.40K | 88.90K | 57.40K | 203.50K | 221.90K |
| Earnings from Continuing Operations | 354.00K | 104.50K | 236.20K | 398.60K | 543.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 354.00K | 104.50K | 236.20K | 398.60K | 543.00K |
| EBIT | 893.30K | 516.20K | 626.70K | 930.60K | 1.10M |
| EBITDA | 1.31M | 928.90K | 1.06M | 1.38M | 1.56M |
| EPS Basic | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 |
| Normalized Basic EPS | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 |
| Normalized Diluted EPS | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 34.52M | 34.39M | 32.93M | 34.19M | 34.19M |
| Average Diluted Shares Outstanding | 34.52M | 35.50M | 32.93M | 35.60M | 34.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |